ZIMMER BIOMET HLDGS DL-01/ US98956P1021 /
| 08.11.2024 08:01:28 | Diff. -0,20 | Volumen | Geld12:09:49 | Brief12:09:49 | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 100,40EUR | -0,20% | 0 Umsatz: 0.00 |
100,30Geld Vol: 60 | 101,25Brief Vol: 60 | 20,03 Mrd.EUR | - | - |
Aktiva
| 2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 2.015,4000 | 2.077,4000 | 2.047,7000 | 2.016,5000 | 1.872,5000 | ||||||
| Immaterielle Vermögensgegenstände | 7.684,6000 | 7.257,6000 | 7.055,5000 | 6.299,8000 | 5.063,8000 | ||||||
| Finanzanlagen | - | - | - | - | - | ||||||
| Anlagevermögen | 19.699,4000 | 19.914,8000 | 19.334,4000 | 18.571,4000 | 16.638,7000 | ||||||
| Vorräte | 2.256,5000 | 2.385 | 2.450,7000 | 2.394,5000 | 2.147,2000 | ||||||
| Forderungen | 1.275,8000 | 1.363,9000 | 1.452,7000 | 1.404,9000 | 1.381,5000 | ||||||
| Liquide Mitteln | 542,8000 | 617,9000 | 802,1000 | 478,5000 | 375,7000 | ||||||
| Umlaufvermögen | 4.427,4000 | 4.723,9000 | 5.083,3000 | 4.885 | 4.427,3000 | ||||||
| Aktiva, gesamt | 24.126,8000 | 24.638,7000 | 24.417,7000 | 23.456,4000 | 21.066 | ||||||
Passiva
| 2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 362,6000 | 400,9000 | 330 | 351,2000 | 354,1000 | ||||||
| Langfristige Schulden | 8.413,7000 | 6.721,4000 | 7.626,5000 | 5.463,7000 | 5.152,2000 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | - | - | - | - | - | ||||||
| Rückstellungen | 999,5000 | 840,1000 | 790,4000 | 665,6000 | - | ||||||
| Verbindlichkeiten | 12.850,7000 | 12.245,9000 | 12.218,3000 | 10.790 | 9.039 | ||||||
| Gezeichnetes Kapital | 3,1000 | 3,1000 | 3,1000 | 3,1000 | 3,1000 | ||||||
| Eigenkapital | 11.276,1000 | 12.392,8000 | 12.199,4000 | 12.666,4000 | 12.027 | ||||||
| Minderheitenanteile | 4,8000 | 4,7000 | 5,2000 | 5,7000 | 6,7000 | ||||||
| Passiva, gesamt | 24.126,8000 | 24.638,7000 | 24.417,7000 | 23.456,4000 | 21.066 | ||||||
Gewinn- und Verlustrechnung
| 2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 7.932,9000 | 7.982,2000 | 7.024,5000 | 7.836,2000 | 6.939,9000 | ||||||
| Abschreibungen (Gesamt) | 595,9000 | 584,3000 | 597,6000 | 615,7000 | 526,8000 | ||||||
| Betriebsergebnis | 33,8000 | 1.137,5000 | -87,8000 | 780,1000 | 696,3000 | ||||||
| Zinsergebnis | -289,3000 | -226,9000 | -212 | -208,4000 | -164,8000 | ||||||
| Ergebnis vor Steuern | -271,1000 | 905,8000 | -274,4000 | 418,4000 | 403,5000 | ||||||
| Ertragsteuern | 108,2000 | -225,7000 | -137 | 16,3000 | 112,3000 | ||||||
| Gewinnanteil Minderheitsgesellschafter | -,1000 | -,1000 | 1,5000 | ,5000 | 1 | ||||||
| Konzernjahresüberschuss | -379,2000 | 1.131,6000 | -138,9000 | 401,6000 | 231,4000 | ||||||
Pro Aktie
Cash Flow
| 2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 1.747,4000 | 1.585,8000 | 1.204,5000 | 1.499,2000 | 1.356,2000 | ||||||
| Cash Flow aus Investitionstätigkeit | -416,6000 | -729,3000 | -613,8000 | -503,6000 | -522 | ||||||
| Cash Flow aus Finanzierungstätigkeit | -1.302,2000 | -779,9000 | -421,8000 | -1.306 | -775,7000 | ||||||
| Veränderung der liquiden Mittel | 18,4000 | 75,1000 | 184,2000 | -323,6000 | -102,8000 | ||||||
| Anzahl der Mitarbeiter | 19.000 | 19.900 | 20.000 | 19.500 | - | ||||||
